Literature DB >> 18605982

Tissue-specific transcription factors in progression of epithelial tumors.

N L Lazarevich1, D I Fleishman.   

Abstract

Dedifferentiation and epithelial-mesenchymal transition are important steps in epithelial tumor progression. A central role in the control of functional and morphological properties of different cell types is attributed to tissue-specific transcription factors which form regulatory cascades that define specification and differentiation of epithelial cells during embryonic development. The main principles of the action of such regulatory systems are reviewed on an example of a network of hepatocyte nuclear factors (HNFs) which play a key role in establishment and maintenance of hepatocytes--the major functional type of liver cells. HNFs, described as proteins binding to promoters of most hepatospecific genes, not only control expression of functional liver genes, but are also involved in regulation of proliferation, morphogenesis, and detoxification processes. One of the central components of the hepatospecific regulatory network is nuclear receptor HNF4alpha. Derangement of the expression of this gene is associated with progression of rodent and human hepatocellular carcinomas (HCCs) and contributes to increase of proliferation, loss of epithelial morphology, and dedifferentiation. Dysfunction of HNF4alpha during HCC progression can be either caused by structural changes of this gene or occurs due to modification of up-stream regulatory signaling pathways. Investigations preformed on a model system of the mouse one-step HCC progression have shown that the restoration of HNF4alpha function in dedifferentiated cells causes partial reversion of malignant phenotype both in vitro and in vivo. Derangement of HNFs function was also described in other tumors of epithelial origin. We suppose that tissue-specific factors that underlie the key steps in differentiation programs of certain tissues and are able to receive or modulate signals from the cell environment might be considered as promising candidates for the role of tumor suppressors in the tissue types where they normally play the most significant role.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18605982     DOI: 10.1134/s0006297908050106

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  6 in total

1.  MicroRNA-feedback loop as a key modulator of liver tumorigenesis and inflammation.

Authors:  Angélique Gougelet; Sabine Colnot
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

Review 2.  Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer.

Authors:  Martha L Peterson; Chunhong Ma; Brett T Spear
Journal:  Semin Cancer Biol       Date:  2011-01-07       Impact factor: 15.707

3.  Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development.

Authors:  William W Lockwood; Ian M Wilson; Bradley P Coe; Raj Chari; Larissa A Pikor; Kelsie L Thu; Luisa M Solis; Maria I Nunez; Carmen Behrens; John Yee; John English; Nevin Murray; Ming-Sound Tsao; John D Minna; Adi F Gazdar; Ignacio I Wistuba; Calum E MacAulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2012-05-21       Impact factor: 3.240

4.  The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.

Authors:  Dianbo Yao; Songlin Peng; Chaoliu Dai
Journal:  BMC Cancer       Date:  2013-09-23       Impact factor: 4.430

5.  VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2.

Authors:  Yao-Hui Gao; Zhao-Xia Wu; Li-Qi Xie; Cai-Xia Li; Yu-Qin Mao; Yan-Tao Duan; Bing Han; San-Feng Han; Yun Yu; Hao-Jie Lu; Peng-Yuan Yang; Tian-Rui Xu; Jing-Lin Xia; Guo-Qiang Chen; Li-Shun Wang
Journal:  Nat Commun       Date:  2017-06-15       Impact factor: 14.919

Review 6.  Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma.

Authors:  Olga Krivtsova; Anna Makarova; Natalia Lazarevich
Journal:  World J Hepatol       Date:  2018-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.